Drug products
-
Thallous Chloride Tl 201
Active Ingredient EXENATIDE SYNTHETIC Proprietary Name BYDUREON Applicant ASTRAZENECA AB Dosage Form;Route SUBCUTANEOUS Strength 2MG/VIAL Application Type N Product Number 1 Approval Date 2012/01/27 RX/OTC/DISCN No Applicant Full Name DISCN
FDA's Approved Drug Products database
